Belinostat is the generic name for the trade name drug Beleodaq®. In some cases, health care professionals may use the trade name, Beleodaq, when referring to the generic drug name, belinostat.

Drug Type: Belinostat is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. This medication is classified as a “­­­­­­­­­histone deacetylase (HDAC) inhibitor”. (For more detail, see “How Belinostat Works” below.)

What Belinostat Is Used For:

• Belinostat is used to treat relapsed or refractory peripheral T-cell lymphoma (PTCL).

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Belinostat Is Given:

• Belinostat is given as an intravenous (IV) infusion over 30 minutes for 5 days in a row. This is repeated every 21 days (3 weeks). (Some patients may require infusion to run over 45 minutes.)

The amount of Belinostat that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.